A citation-based method for searching scientific literature

Ruiying Zhao, Feng Yao, Chan Xiang, Jikai Zhao, Zhanxian Shang, Lianying Guo, Wenjie Ding, Shengji Ma, Anbo Yu, Jinchen Shao, Lei Zhu, Yuchen Han. J Pathol Clin Res 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Fluorescence in situ hybridization in surgical pathology: principles and applications.
Liang Cheng, Shaobo Zhang, Lisha Wang, Gregory T MacLennan, Darrell D Davidson. J Pathol Clin Res 2017
17
100

A newborn with a large NTRK fusion positive infantile fibrosarcoma successfully treated with larotrectinib.
Kenneth J Caldwell, Esther De La Cuesta, Cara Morin, Alberto Pappo, Sara Helmig. Pediatr Blood Cancer 2020
4
100

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, Steven G DuBois, Ulrik N Lassen, George D Demetri, Michael Nathenson, Robert C Doebele, Anna F Farago, Alberto S Pappo,[...]. N Engl J Med 2018
100

Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer.
Mariangela Russo, Sandra Misale, Ge Wei, Giulia Siravegna, Giovanni Crisafulli, Luca Lazzari, Giorgio Corti, Giuseppe Rospo, Luca Novara, Benedetta Mussolin,[...]. Cancer Discov 2016
171
100

Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations.
Alexander Drilon, Sai-Hong Ignatius Ou, Byoung Chul Cho, Dong-Wan Kim, Jeeyun Lee, Jessica J Lin, Viola W Zhu, Myung-Ju Ahn, D Ross Camidge, Judy Nguyen,[...]. Cancer Discov 2018
161
100

Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.
Peter J Cook, Rozario Thomas, Ram Kannan, Esther Sanchez de Leon, Alexander Drilon, Marc K Rosenblum, Maurizio Scaltriti, Robert Benezra, Andrea Ventura. Nat Commun 2017
37
100

A function-structure model for NGF-activated TRK.
M E Cunningham, L A Greene. EMBO J 1998
44
100

Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum.
Marick Laé, Paul Fréneaux, Xavier Sastre-Garau, Olfa Chouchane, Brigitte Sigal-Zafrani, Anne Vincent-Salomon. Mod Pathol 2009
105
100

The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.
Gang Wu, Alexander K Diaz, Barbara S Paugh, Sherri L Rankin, Bensheng Ju, Yongjin Li, Xiaoyan Zhu, Chunxu Qu, Xiang Chen, Junyuan Zhang,[...]. Nat Genet 2014
579
100

Myxoid Spindle Cell Sarcoma With LMNA-NTRK Fusion: Expanding the Morphologic Spectrum of NTRK-Rearranged Tumors.
Yik Ka So, Chit Chow, Ka Fai To, John K C Chan, W Cheuk. Int J Surg Pathol 2020
11
100


The signaling adapters fibroblast growth factor receptor substrate 2 and 3 are activated by the thyroid TRK oncoproteins.
Valeria Ranzi, Susan O Meakin, Claudia Miranda, Piera Mondellini, Marco A Pierotti, Angela Greco. Endocrinology 2003
25
100

NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
James P Solomon, Irina Linkov, Andrea Rosado, Kerry Mullaney, Ezra Y Rosen, Denise Frosina, Achim A Jungbluth, Ahmet Zehir, Ryma Benayed, Alexander Drilon,[...]. Mod Pathol 2020
146
100

ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition.
Kathryn G Roberts, Laura J Janke, Yaqi Zhao, Aman Seth, Jing Ma, David Finkelstein, Steve Smith, Kevin Ebata, Brian B Tuch, Stephen P Hunger,[...]. Blood 2018
22
100

TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor.
J C Arevalo, B Conde, B L Hempstead, M V Chao, D Martin-Zanca, P Perez. Mol Cell Biol 2000
78
100

The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets.
Enzo Medico, Mariangela Russo, Gabriele Picco, Carlotta Cancelliere, Emanuele Valtorta, Giorgio Corti, Michela Buscarino, Claudio Isella, Simona Lamba, Barbara Martinoglio,[...]. Nat Commun 2015
176
100

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.
Kathryn G Roberts, Yongjin Li, Debbie Payne-Turner, Richard C Harvey, Yung-Li Yang, Deqing Pei, Kelly McCastlain, Li Ding, Charles Lu, Guangchun Song,[...]. N Engl J Med 2014
763
100

NTRK fusion-positive colorectal cancer in Japanese population.
Junpei Yonemaru, Taiki Hashimoto, Daisuke Takayanagi, Tomoaki Naka, Yasushi Yatabe, Yukihide Kanemitsu, Kouya Shiraishi, Shigeki Sekine. Pathol Int 2021
2
100

ETV6-NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual.
F Grabellus, K Worm, A Willruth, K J Schmitz, F Otterbach, H A Baba, R Kimmig, K A Metz. Breast 2005
31
100

Neurotrophin-regulated signalling pathways.
Louis F Reichardt. Philos Trans R Soc Lond B Biol Sci 2006
100

NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line.
Su Jin Lee, Gang Gary Li, Seung Tae Kim, Min Eui Hong, Jiryeon Jang, Nara Yoon, Soo Min Ahn, Danielle Murphy, Jason Christiansen, Ge Wei,[...]. Oncotarget 2015
45
100

NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma.
Yuekun Wang, Piaopiao Long, Yu Wang, Wenbin Ma. Front Oncol 2020
4
100

A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
Nikita Makretsov, May He, Malcolm Hayes, Stephen Chia, Doug E Horsman, Poul H B Sorensen, David G Huntsman. Genes Chromosomes Cancer 2004
82
100

NTRK gene fusions in melanoma: detection, prevalence and potential therapeutic implications.
Andrea Forschner, Stephan Forchhammer, Irina Bonzheim. J Dtsch Dermatol Ges 2020
4
100

Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays.
Nicole Pfarr, Martina Kirchner, Ulrich Lehmann, Jonas Leichsenring, Sabine Merkelbach-Bruse, Julia Glade, Michael Hummel, Fabian Stögbauer, Annika Lehmann, Marcel Trautmann,[...]. Genes Chromosomes Cancer 2020
29
100

Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
Alanna J Church, Monica L Calicchio, Valentina Nardi, Alena Skalova, Andre Pinto, Deborah A Dillon, Carmen R Gomez-Fernandez, Namitha Manoj, Josh D Haimes, Joshua A Stahl,[...]. Mod Pathol 2018
67
100



NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome.
Xiaonan Zhao, Chelsea Kotch, Elizabeth Fox, Lea F Surrey, Gerald B Wertheim, Zubair W Baloch, Fumin Lin, Vinodh Pillai, Minjie Luo, Portia A Kreiger,[...]. JCO Precis Oncol 2021
5
100

A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors.
Anna Forsythe, Wei Zhang, Uwe Phillip Strauss, Marc Fellous, Maesumeh Korei, Karen Keating. Ther Adv Med Oncol 2020
7
100

Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
Alena Skálová, Tomas Vanecek, Radek Sima, Jan Laco, Ilan Weinreb, Bayardo Perez-Ordonez, Ivo Starek, Marie Geierova, Roderrick H W Simpson, Fabricio Passador-Santos,[...]. Am J Surg Pathol 2010
521
100

Primary and Metastatic Melanoma With NTRK Fusions.
Cecilia Lezcano, Alexander N Shoushtari, Charlotte Ariyan, Travis J Hollmann, Klaus J Busam. Am J Surg Pathol 2018
46
100

NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm.
Daniel D Wong, Ana Cristina Vargas, Fiona Bonar, Fiona Maclean, Joseph Kattampallil, Colin Stewart, Ban Sulaiman, Leonardo Santos, Anthony J Gill. Pathology 2020
13
100

Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
Yuri Sheikine, Frank C Kuo, Neal I Lindeman. J Clin Oncol 2017
26
100

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.
Cristina Tognon, Stevan R Knezevich, David Huntsman, Calvin D Roskelley, Natalya Melnyk, Joan A Mathers, Laurence Becker, Fatima Carneiro, Nicol MacPherson, Doug Horsman,[...]. Cancer Cell 2002
552
100

Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer.
Anna F Farago, Long P Le, Zongli Zheng, Alona Muzikansky, Alexander Drilon, Manish Patel, Todd M Bauer, Stephen V Liu, Sai-Hong I Ou, David Jackman,[...]. J Thorac Oncol 2015
146
100

What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).
A Drilon, G Li, S Dogan, M Gounder, R Shen, M Arcila, L Wang, D M Hyman, J Hechtman, G Wei,[...]. Ann Oncol 2016
170
100

The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition.
Elena Ardini, Roberta Bosotti, Andrea Lombardi Borgia, Cristina De Ponti, Alessio Somaschini, Rosaria Cammarota, Nadia Amboldi, Laura Raddrizzani, Andrea Milani, Paola Magnaghi,[...]. Mol Oncol 2014
95
100

A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors.
Alexander Drilon, Ramamoorthy Nagasubramanian, James F Blake, Nora Ku, Brian B Tuch, Kevin Ebata, Steve Smith, Veronique Lauriault, Gabrielle R Kolakowski, Barbara J Brandhuber,[...]. Cancer Discov 2017
190
100

NTRK Fusions, from the Diagnostic Algorithm to Innovative Treatment in the Era of Precision Medicine.
Federica Zito Marino, Francesca Pagliuca, Andrea Ronchi, Immacolata Cozzolino, Marco Montella, Massimiliano Berretta, Maria Elena Errico, Vittoria Donofrio, Roberto Bianco, Renato Franco. Int J Mol Sci 2020
20
100

The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.
Antonietta Rosella Farina, Lucia Cappabianca, Pierdomenico Ruggeri, Luciana Gneo, Cristina Pellegrini, Maria-Concetta Fargnoli, Andrew Reay Mackay. J Exp Clin Cancer Res 2018
15
100

Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples.
Kurtis D Davies, Anh T Le, Jamie Sheren, Hala Nijmeh, Katherine Gowan, Kenneth L Jones, Marileila Varella-Garcia, Dara L Aisner, Robert C Doebele. J Thorac Oncol 2018
78
100

Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours.
P Garrido, R Hladun, E de Álava, R Álvarez, F Bautista, F López-Ríos, R Colomer, F Rojo. Clin Transl Oncol 2021
3
100

NTRK2 Fusion driven pediatric glioblastoma: Identification of oncogenic Drivers via integrative Genome and transcriptome profiling.
Heidi M Britton, Adrian B Levine, Yaoqing Shen, Karen Mungall, Jonathan Serrano, Matija Snuderl, Erin Pleasance, Steven J M Jones, Janessa Laskin, Marco A Marra,[...]. Clin Case Rep 2021
1
100

Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment Followed by Sensitive Next-Generation Sequencing.
Danielle A Murphy, Heather A Ely, Robert Shoemaker, Aaron Boomer, Brady P Culver, Ian Hoskins, Josh D Haimes, Ryan D Walters, Diane Fernandez, Joshua A Stahl,[...]. Appl Immunohistochem Mol Morphol 2017
51
100

Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
Jaclyn F Hechtman, Ryma Benayed, David M Hyman, Alexander Drilon, Ahmet Zehir, Denise Frosina, Maria E Arcila, Snjezana Dogan, David S Klimstra, Marc Ladanyi,[...]. Am J Surg Pathol 2017
199
100

Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion.
Bin Xu, Mohamed R Haroon Al Rasheed, Cristina R Antonescu, Deepu Alex, Denise Frosina, Ronald Ghossein, Achim A Jungbluth, Nora Katabi. Histopathology 2020
25
100

Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA.
J Meyer, M Rhein, B Schiedlmeier, O Kustikova, C Rudolph, K Kamino, T Neumann, M Yang, A Wahlers, B Fehse,[...]. Leukemia 2007
32
100


TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.
Antonella Tacconelli, Antonietta R Farina, Lucia Cappabianca, Giuseppina Desantis, Alessandra Tessitore, Antonella Vetuschi, Roberta Sferra, Nadia Rucci, Beatrice Argenti, Isabella Screpanti,[...]. Cancer Cell 2004
143
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.